TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -60.29%5.36M | -5.26%28.75M | -21.54%18.82M | -12.68%13.5M | -16.22%5.27M | 225.18%30.34M | 142.81%23.99M | 192.07%15.46M | 176.12%6.29M | -88.80%9.33M |
Operating income | -60.29%5.36M | -5.26%28.75M | -21.54%18.82M | -12.68%13.5M | -16.22%5.27M | 225.18%30.34M | 142.81%23.99M | 192.07%15.46M | 176.12%6.29M | -88.80%9.33M |
Cost of sales | 69.16%-3.06M | 22.85%-21.19M | 41.70%-13.07M | 31.64%-9.92M | 34.97%-3.69M | -429.39%-27.47M | -308.66%-22.42M | ---14.51M | ---5.67M | 87.71%-5.19M |
Operating expenses | 69.16%-3.06M | 22.85%-21.19M | 41.70%-13.07M | 31.64%-9.92M | 34.97%-3.69M | -429.39%-27.47M | -308.66%-22.42M | -14.51M | -5.67M | 87.71%-5.19M |
Gross profit | -35.72%2.3M | 162.97%7.56M | 266.65%5.75M | 276.95%3.58M | 154.66%1.58M | -30.64%2.87M | -64.31%1.57M | 950K | -72.70%622K | -89.92%4.14M |
Employee expense | 11.15%-2.46M | -227.88%-6.01M | -304.55%-4.36M | -272.45%-2.77M | -83.09%-1.36M | 86.26%-1.83M | 90.95%-1.08M | 92.74%-744K | 88.08%-745K | 69.12%-13.34M |
Impairment and provision | ---- | ---313K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -273.36%-1M |
-Other impairment is provision | ---- | ---313K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -273.36%-1M |
Special items of operating profit | 4.42%-3.07M | -25.05%-5.28M | -36.15%-3.99M | -133.62%-3.21M | -76.88%-1.67M | 44.79%-4.22M | -420.59%-2.93M | 79.74%-1.37M | 62.17%-943K | 11.15%-7.64M |
Operating profit | -34.50%-3.23M | -27.20%-4.05M | -6.57%-2.6M | -105.48%-2.4M | -35.83%-1.45M | 82.17%-3.18M | 81.49%-2.44M | 90.05%-1.17M | 83.51%-1.07M | -76.15%-17.84M |
Financing cost | 76.46%-182K | -81.44%-1.26M | -130.83%-1.11M | -141.56%-773K | -119.88%-365K | -63.92%-695K | -576.06%-480K | -350.70%-320K | -268.89%-166K | -15.22%-424K |
Earning before tax | -7.47%-3.41M | -36.93%-5.31M | -27.01%-3.71M | -113.24%-3.17M | -47.16%-1.81M | 78.78%-3.88M | 77.96%-2.92M | 87.40%-1.49M | 81.07%-1.23M | -74.02%-18.26M |
Tax | ---- | ---32K | ---- | ---- | ---- | ---- | ---- | ---- | -118.35%-178K | 88.83%3.38M |
After-tax profit from continuing operations | -7.47%-3.41M | -37.75%-5.34M | -27.01%-3.71M | -113.24%-3.17M | -28.58%-1.81M | 73.96%-3.88M | 73.53%-2.92M | 85.10%-1.49M | 74.54%-1.41M | -70.97%-14.88M |
After-tax profit from non-continuing business | ---- | 586.62%6.88M | 887.05%7.05M | 2,180.39%7.43M | ---- | ---1.41M | ---896K | ---357K | ---- | ---- |
Earning after tax | -180.16%-3.41M | 129.08%1.54M | 187.78%3.35M | 330.57%4.25M | -28.58%-1.81M | 64.47%-5.29M | 65.39%-3.81M | 81.52%-1.85M | 74.54%-1.41M | -70.97%-14.88M |
Profit attributable to shareholders | -180.16%-3.41M | 129.08%1.54M | 187.78%3.35M | 330.57%4.25M | -28.58%-1.81M | 64.47%-5.29M | 65.39%-3.81M | 81.52%-1.85M | 74.54%-1.41M | -70.97%-14.88M |
Basic earnings per share | -126.74%-0.0315 | 113.33%0.02 | 159.42%0.076 | 289.39%0.1178 | 0.00%-0.05 | 74.58%-0.15 | -481.36%-0.1279 | -212.56%-0.0622 | -354.55%-0.05 | -3,177.78%-0.59 |
Diluted earnings per share | -126.74%-0.0315 | 113.33%0.02 | 159.42%0.076 | 289.39%0.1178 | 0.00%-0.05 | 74.58%-0.15 | -481.36%-0.1279 | -0.0622 | -354.55%-0.05 | -3,177.78%-0.59 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | -- | -- | Pak Chun Certified Public Accountants Limited | -- | -- | -- | Unitai Pak Chun (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.